Skip to content

Welcome to Discover Pharma! Today is : November 12, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug Discovery & Development

  • Drug Discovery & Development

    First participant dosed in ACT-EARLY: A landmark prevention study

    BridgeBio Pharma has announced that the first participant has been [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development,Manufacturing & Supply Chain

    ReiThera to showcase AAV breakthroughs and expand US reach

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development

    FTD trial milestone reached as Vesper Bio enrols first asymptomatic GRN carriers

    Vesper Bio has reached a key enrolment milestone in its [...]

    May 5, 2026
  • Drug Discovery & Development

    Rectify’s liver drug shows promise in models as company targets PSC with new mechanism

    Company says dual-acting oral therapy improves bile acid transport and [...]

    May 5, 2026
  • Drug Discovery & Development

    Speed Surge: ten23 health launches robot-assisted pilot fill line to fast-track drug development

    New non-GMP Line 0 offering is designed to give customers [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development

    BioAscent taps new VP of Alliance Management to drive global growth

    BioAscent has appointed seasoned drug discovery executive Dr James Hitchin [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development

    QuantHealth introduces clinical-stage AI foundation model for trial design

    The new platform, trained on 100 million patient records, aims [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development

    MindSpire secures £850K to launch SONA wearable and revolutionise stress management with AI-driven vagus nerve tech

    Neurotech start-up MindSpire has raised £850,000 in pre-seed funding to [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Manufacturing & Supply Chain

    Colorcon and ASHA Cellulose partner to advance barrier membrane technologies for pharma and nutra formulations

    Colorcon, a specialist in film coatings, excipients, and controlled release [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development

    High hopes: Ajna turns psychedelics and cannabis into prescription science

    May 5, 2026
Previous767778Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Mission Therapeutics signs US$292M deal for acute kidney injury programme
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Research & Development
  • Medicus receives FDA feedback and IRB approval for Teverelix Phase 2 urinary retention trial
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development
  • Compass Pathways study explores monitoring and support in COMP360 PTSD trial
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top